THE THERAPEUTIC MANAGEMENT OF DESTRUCTIVE FORMS OF CHRONIC PERIODONTITIS WITH MODERN BONE-PLASTIC MATERIALS

In the context of destructive forms of chronic periodontitis, where traditional therapies are unable to restore lost bone and tissue, modern bone-plastic (bone-regenerative) materials are essential. Recent developments have concentrated on biomaterials that facilitate bone regeneration and regulate infection and inflammation, providing more comprehensive and effective treatment options. Synthetic and Alloplastic Grafts: Composite hydrogels, hydroxyapatite (HA), and β-tricalcium phosphate (β-TCP) are materials that are frequently employed. These serve as scaffolds for the development of new bone and can be customised to meet specific regenerative requirements. Barrier Membranes: In guided tissue and bone regeneration, membranes made from synthetic and natural materials are employed to prevent soft tissue from entering the area that requires repair, while allowing bone and ligament cells to fill in the gap. Newer materials are functionalised and drug-loaded to improve their antibacterial, anti-inflammatory, and osteogenic properties. These materials may contain pharmaceuticals (e.g., antibiotics, anti-inflammatories, and growth factors) or bioactive agents (e.g., quercetin, melatonin). Clinical Results and Effectiveness Bone Regeneration: In comparison to HA-based materials, β-TCP-based materials exhibit the most significant stimulation of bone formation and favourable alterations in bone metabolism markers, particularly in moderate periodontitis. In both animal studies and real-world medical situations, hydrogels and nanocomposites that contain substances such as dexamethasone, quercetin, or copper-calcium compounds are highly effective in combating infections, reducing inflammation, and promoting bone healing. Delivery Systems that are Innovative: The synchronisation of anti-inflammatory and bone-regenerative phases enhances outcomes through the use of injectable hydrogels and time-programmed drug release membranes, which ensure sustained local delivery. Key Benefits of the Material/Approach Evidence Grafts that are based on β-TCP: Metabolic equilibrium and robust bone regeneration Hydrogels that are laden with drugs, Bone, antibacterial, and anti-inflammatory Core-shell nanofiber membranes: Bone defect recovery through sequential drug discharge Alloplastic/synthetic grafts Scaffolding that is both effective and customizable. In conclusion, the treatment of destructive chronic periodontitis is considerably enhanced by contemporary bone-plastic materials, particularly those that combine synthetic scaffolds with antibacterial and anti-inflammatory agents. These advancements represent a significant improvement over conventional therapies, as they facilitate more predictable bone regeneration and improved control of infection and inflammation.